Literature DB >> 1647997

Abnormal regulation of protein tyrosine phosphatase activities in skeletal muscle of insulin-resistant humans.

M C McGuire1, R M Fields, B L Nyomba, I Raz, C Bogardus, N K Tonks, J Sommercorn.   

Abstract

Insulin resistance in skeletal muscle may be an expression of the genetic basis of a common form of non-insulin-dependent diabetes mellitus (NIDDM) in humans. Impaired insulin action results from an apparent postreceptor defect in insulin signal transduction that limits the influence of the hormone on various protein serine/threonine kinases and phosphatases that are thought to contribute to the mechanism by which insulin affects intracellular events. The fact that numerous responses to insulin are affected suggests that the cause of insulin resistance involves an early step in insulin action. Therefore, we examined the influence of insulin on protein tyrosine phosphatase (PTPase) activities, which may counteract the protein tyrosine kinase activity of the insulin receptor in skeletal muscle of insulin-sensitive and insulin-resistant humans. Insulin infusion in vivo produced a rapid 25% suppression of soluble-PTPase activity in muscle of insulin-sensitive subjects, but this response was severely impaired in subjects who were insulin resistant. Insulin did not affect PTPase activity in the particulate fraction of muscle from either group, but basal particulate activity was 33% higher in resistant subjects than in sensitive subjects. Either or both of these abnormal characteristics of PTPase activities could be central to the causes of insulin resistance and NIDDM.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1647997     DOI: 10.2337/diab.40.7.939

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  26 in total

Review 1.  Transgenic mouse models resistant to diet-induced metabolic disease: is energy balance the key?

Authors:  Laura A A Gilliam; P Darrell Neufer
Journal:  J Pharmacol Exp Ther       Date:  2012-06-13       Impact factor: 4.030

2.  Insulin receptor and epidermal growth factor receptor dephosphorylation by three major rat liver protein-tyrosine phosphatases expressed in a recombinant bacterial system.

Authors:  N Hashimoto; W R Zhang; B J Goldstein
Journal:  Biochem J       Date:  1992-06-01       Impact factor: 3.857

3.  Molecular dynamics simulations of protein-tyrosine phosphatase 1B. II. substrate-enzyme interactions and dynamics.

Authors:  G H Peters; T M Frimurer; J N Andersen; O H Olsen
Journal:  Biophys J       Date:  2000-05       Impact factor: 4.033

4.  Overexpression of the LAR (leukocyte antigen-related) protein-tyrosine phosphatase in muscle causes insulin resistance.

Authors:  J M Zabolotny; Y B Kim; O D Peroni; J K Kim; M A Pani; O Boss; L D Klaman; S Kamatkar; G I Shulman; B B Kahn; B G Neel
Journal:  Proc Natl Acad Sci U S A       Date:  2001-04-17       Impact factor: 11.205

5.  Rosiglitazone ameliorates abnormal expression and activity of protein tyrosine phosphatase 1B in the skeletal muscle of fat-fed, streptozotocin-treated diabetic rats.

Authors:  Yong Wu; Jing Ping Ouyang; Ke Wu; Shi Shun Wang; Chong Yuan Wen; Zheng Yuan Xia
Journal:  Br J Pharmacol       Date:  2005-09       Impact factor: 8.739

Review 6.  Protein-tyrosine phosphatase-1B acts as a negative regulator of insulin signal transduction.

Authors:  J C Byon; A B Kusari; J Kusari
Journal:  Mol Cell Biochem       Date:  1998-05       Impact factor: 3.396

7.  Alterations in skeletal muscle protein-tyrosine phosphatase activity and expression in insulin-resistant human obesity and diabetes.

Authors:  F Ahmad; J L Azevedo; R Cortright; G L Dohm; B J Goldstein
Journal:  J Clin Invest       Date:  1997-07-15       Impact factor: 14.808

8.  Altered basal and insulin-stimulated phosphotyrosine phosphatase (PTPase) activity in skeletal muscle from NIDDM patients compared with control subjects.

Authors:  D Worm; J Vinten; P Staehr; J E Henriksen; A Handberg; H Beck-Nielsen
Journal:  Diabetologia       Date:  1996-10       Impact factor: 10.122

Review 9.  Molecular mechanism of insulin resistance in obesity and type 2 diabetes.

Authors:  Kangduk Choi; Young-Bum Kim
Journal:  Korean J Intern Med       Date:  2010-06-01       Impact factor: 3.165

10.  Decreased tyrosine kinase activity in partially purified insulin receptors from muscle of young, non-obese first degree relatives of patients with type 2 (non-insulin-dependent) diabetes mellitus.

Authors:  A Handberg; A Vaag; J Vinten; H Beck-Nielsen
Journal:  Diabetologia       Date:  1993-07       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.